Insider · CIK 0001694903

Uihlein Richard E

Reports to the SEC for 1 company · NORCROSS, GA

sec.gov

Transactions

Companies

Filings

CIK

0001694903

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-07-31	GALTGALECTIN THERAPEUTICS INCM Exercise/Conversion	Director, 10% Owner	MExercise/Conversion	+31.8M sh	$3.00	+$95.5M	42,162,911
2026-07-31	GALTGALECTIN THERAPEUTICS INCM Exercise/Conversion	Director, 10% Owner	MExercise/Conversion	+2.55M sh	$4.05	+$10.3M	44,713,843
2026-07-31	GALTGALECTIN THERAPEUTICS INC · Line of Credit Convertible NotesM Exercise/Conversion	Director, 10% Owner	MExercise/Conversion	—	$95475705.00	—	0
2026-07-31	GALTGALECTIN THERAPEUTICS INC · Line of Credit Convertible NotesM Exercise/Conversion	Director, 10% Owner	MExercise/Conversion	—	$10331275.00	—	0
2026-01-16	GALTGALECTIN THERAPEUTICS INCA Award	Director, 10% Owner	AAward	+13.2K sh	$3.04	+$40K	10,332,676
2026-01-16	GALTGALECTIN THERAPEUTICS INC · Stock option (right to buy)A Award	Director, 10% Owner	AAward	+60K sh	—	—	60,000
2025-01-23	GALTGALECTIN THERAPEUTICS INCA Award	Director, 10% Owner	AAward	+32.5K sh	$1.23	+$40K	10,301,271
2025-01-23	GALTGALECTIN THERAPEUTICS INC · Stock Option (right to buy)A Award	Director, 10% Owner	AAward	+60K sh	—	—	60,000
2024-01-24	GALTGALECTIN THERAPEUTICS INCA Award	Director, 10% Owner	AAward	+23.3K sh	$1.72	+$40K	10,268,751
2024-01-24	GALTGALECTIN THERAPEUTICS INC · Stock Option (right to buy)A Award	Director, 10% Owner	AAward	+50K sh	—	—	50,000
2023-09-26	GALTGALECTIN THERAPEUTICS INCM Exercise/Conversion	Director, 10% Owner	MExercise/Conversion	+200K sh	$3.26	+$652K	10,035,495
2023-09-26	GALTGALECTIN THERAPEUTICS INCM Exercise/Conversion	Director, 10% Owner	MExercise/Conversion	+200K sh	$3.00	+$600K	10,235,495
2023-09-26	GALTGALECTIN THERAPEUTICS INCM Exercise/Conversion	Director, 10% Owner	MExercise/Conversion	+1.47M sh	$5.00	+$7.33M	9,466,495
2023-09-26	GALTGALECTIN THERAPEUTICS INCM Exercise/Conversion	Director, 10% Owner	MExercise/Conversion	+170K sh	$5.00	+$850K	9,635,495
2023-09-26	GALTGALECTIN THERAPEUTICS INCM Exercise/Conversion	Director, 10% Owner	MExercise/Conversion	+200K sh	$3.00	+$600K	9,835,495
2023-09-26	GALTGALECTIN THERAPEUTICS INC · Common Stock Purchase Warrant (right to buy)M Exercise/Conversion	Director, 10% Owner	MExercise/Conversion	−1.47M sh	—	—	0
2023-09-26	GALTGALECTIN THERAPEUTICS INC · Common Stock Purchase Warrant (right to buy)M Exercise/Conversion	Director, 10% Owner	MExercise/Conversion	−170K sh	—	—	330,000
2023-09-26	GALTGALECTIN THERAPEUTICS INC · Common Stock Purchase Warrant (right to buy)M Exercise/Conversion	Director, 10% Owner	MExercise/Conversion	−200K sh	—	—	0
2023-09-26	GALTGALECTIN THERAPEUTICS INC · Common Stock Purchase Warrant (right to buy)M Exercise/Conversion	Director, 10% Owner	MExercise/Conversion	−200K sh	—	—	0
2023-09-26	GALTGALECTIN THERAPEUTICS INC · Common Stock Purchase Warrant (right to buy)M Exercise/Conversion	Director, 10% Owner	MExercise/Conversion	−200K sh	—	—	0
2023-01-26	GALTGALECTIN THERAPEUTICS INCA Award	Director, 10% Owner	AAward	+36K sh	$1.11	+$40K	7,999,291
2023-01-26	GALTGALECTIN THERAPEUTICS INC · Stock Option (right to buy)A Award	Director, 10% Owner	AAward	+40K sh	—	—	40,000
2022-01-24	GALTGALECTIN THERAPEUTICS INCA Award	Director, 10% Owner	AAward	+17.7K sh	$1.98	+$35K	7,936,677
2022-01-24	GALTGALECTIN THERAPEUTICS INC · Stock Option (right to buy)A Award	Director, 10% Owner	AAward	+40K sh	—	—	40,000
2021-12-20	GALTGALECTIN THERAPEUTICS INC · Convertible NoteA Award	Director, 10% Owner	AAward	+1.84M sh	$10000000.00	+$18.4T	10,000,000
2021-09-17	GALTGALECTIN THERAPEUTICS INC · Convertible NoteA Award	Director, 10% Owner	AAward	+1.16M sh	$10000000.00	+$11.6T	10,000,000
2021-04-16	GALTGALECTIN THERAPEUTICS INC · Convertible NoteA Award	Director, 10% Owner	AAward	+2M sh	$10000000.00	+$20T	10,000,000
2021-03-25	GALTGALECTIN THERAPEUTICS INC · Stock option (right to buy)A Award	Director, 10% Owner	AAward	+40K sh	—	—	40,000
2021-03-25	GALTGALECTIN THERAPEUTICS INC · Stock option (right to buy)A Award	Director, 10% Owner	AAward	+70K sh	—	—	70,000
2020-09-04	GALTGALECTIN THERAPEUTICS INCP Purchase	Director, 10% Owner	PPurchase	+10K sh	$2.55	+$25.5K	7,893,191
2020-02-13	GALTGALECTIN THERAPEUTICS INCM Exercise/Conversion	Director, 10% Owner	MExercise/Conversion	+46.9K sh	$2.39	+$112K	7,864,553
2020-02-13	GALTGALECTIN THERAPEUTICS INCM Exercise/Conversion	Director, 10% Owner	MExercise/Conversion	+18.6K sh	$4.72	+$88K	7,883,191
2020-02-13	GALTGALECTIN THERAPEUTICS INC · Stock option (right to buy)M Exercise/Conversion	Director, 10% Owner	MExercise/Conversion	−46.9K sh	—	—	0
2020-02-13	GALTGALECTIN THERAPEUTICS INC · Stock option (right to buy)M Exercise/Conversion	Director, 10% Owner	MExercise/Conversion	−18.6K sh	—	—	21,362
2020-01-09	GALTGALECTIN THERAPEUTICS INCA Award	Director, 10% Owner	AAward	+12.2K sh	$2.86	+$35K	7,817,678
2020-01-09	GALTGALECTIN THERAPEUTICS INC · Stock option (right to buy)A Award	Director, 10% Owner	AAward	+45K sh	—	—	45,000
2019-05-31	GALTGALECTIN THERAPEUTICS INCP Purchase	Director, 10% Owner	PPurchase	+4.67M sh	$4.28	+$20M	7,801,385
2019-05-31	GALTGALECTIN THERAPEUTICS INCP Purchase	Director, 10% Owner	PPurchase	+7,710 sh	$4.28	+$33K	27,710
2019-05-31	GALTGALECTIN THERAPEUTICS INC · Common Stock Purchase Warrant (right to buy)P Purchase	Director, 10% Owner	PPurchase	+15.6M sh	—	—	15,576,322
2019-05-31	GALTGALECTIN THERAPEUTICS INC · Common Stock Purchase Warrant (right to buy)P Purchase	Director, 10% Owner	PPurchase	+25.7K sh	—	—	25,700
2019-05-31	GALTGALECTIN THERAPEUTICS INCP Purchase	Director, 10% Owner	PPurchase	+4.67M sh	$4.28	+$20M	7,801,385
2019-05-31	GALTGALECTIN THERAPEUTICS INCP Purchase	Director, 10% Owner	PPurchase	+7,710 sh	$4.28	+$33K	27,710
2019-05-31	GALTGALECTIN THERAPEUTICS INC · Common Stock Purchase Warrant (right to buy)P Purchase	Director, 10% Owner	PPurchase	+25.7K sh	—	—	25,700
2019-05-29	GALTGALECTIN THERAPEUTICS INCM Exercise/Conversion	Director, 10% Owner	MExercise/Conversion	+500K sh	$5.00	+$2.5M	3,128,489
2019-05-29	GALTGALECTIN THERAPEUTICS INC · Common Stock Purchase Warrant (right to buy)M Exercise/Conversion	Director, 10% Owner	MExercise/Conversion	−500K sh	—	—	966,204
2019-05-29	GALTGALECTIN THERAPEUTICS INCM Exercise/Conversion	Director, 10% Owner	MExercise/Conversion	+500K sh	$5.00	+$2.5M	3,128,489
2019-05-29	GALTGALECTIN THERAPEUTICS INC · Common Stock Purchase Warrant (right to buy)P Purchase	Director, 10% Owner	PPurchase	+15.6M sh	—	—	15,576,322
2019-05-21	GALTGALECTIN THERAPEUTICS INC · Common Stock Purchase Warrant (right to buy)M Exercise/Conversion	Director, 10% Owner	MExercise/Conversion	−500K sh	—	—	966,204
2019-04-09	GALTGALECTIN THERAPEUTICS INCP Purchase	Director, 10% Owner	PPurchase	+20.7K sh	$4.82	+$99.9K	2,628,489
2019-04-05	GALTGALECTIN THERAPEUTICS INCP Purchase	Director, 10% Owner	PPurchase	+21K sh	$4.81	+$101K	2,607,789

Recent filings

Accepted (ET)
Aug 44
Uihlein Richard E0001133416-26-000065
SEC(opens sec.gov)
Jan 214
Uihlein Richard E0001133416-26-000020
SEC(opens sec.gov)
Jan 274
Uihlein Richard E0001133416-25-000022
SEC(opens sec.gov)
Feb 74
Uihlein Richard E0001133416-24-000026
SEC(opens sec.gov)
Sep 274
Uihlein Richard E0001133416-23-000075
SEC(opens sec.gov)

Companies

GALECTIN THERAPEUTICS INCDirector, 10% OwnerGALT

Address

4960 PEACHTREE INDUSTRIAL BLVD SUITE 240

NORCROSS, GA, 30071